Nathaniel R. Landau
#158,890
Most Influential Person Now
Nathaniel R. Landau's AcademicInfluence.com Rankings
Nathaniel R. Landaubiology Degrees
Biology
#12418
World Rank
#15893
Historical Rank
Virology
#302
World Rank
#309
Historical Rank
Cell Biology
#653
World Rank
#667
Historical Rank
Immunology
#829
World Rank
#852
Historical Rank
Download Badge
Biology
Nathaniel R. Landau's Degrees
- PhD Molecular and Cell Biology University of California, Berkeley
- Bachelors Biochemistry University of California, Berkeley
Why Is Nathaniel R. Landau Influential?
(Suggest an Edit or Addition)Nathaniel R. Landau's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Identification of a major co-receptor for primary isolates of HIV-1 (1996) (3874)
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection (1996) (3208)
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals (1997) (1479)
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progression (1996) (1449)
- Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. (1995) (1322)
- Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif (2003) (965)
- Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity (1995) (917)
- SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates (2012) (754)
- Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain (1994) (743)
- CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 (1996) (712)
- Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome (2004) (617)
- SAMHD1 restricts HIV-1 infection in resting CD4+ T cells (2012) (540)
- Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells (1984) (528)
- Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis (1993) (416)
- BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias (1991) (397)
- APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons (2006) (386)
- Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity (1990) (367)
- Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry (1997) (336)
- A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). (2004) (334)
- Complementary function of the two catalytic domains of APOBEC3G. (2005) (324)
- APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication* (2004) (309)
- Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range (1991) (291)
- Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr (1995) (290)
- The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4 (1988) (275)
- Packaging system for rapid production of murine leukemia virus vectors with variable tropism (1992) (269)
- Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* (1997) (257)
- CCR5 is a receptor for Staphylococcus aureus leukotoxin ED (2012) (252)
- A dominant block to HIV-1 replication at reverse transcription in simian cells (2002) (249)
- Intrinsic host restrictions to HIV-1 and mechanisms of viral escape (2015) (237)
- Human Immunodeficiency Virus Type 1 Vpr Induces the Degradation of the UNG and SMUG Uracil-DNA Glycosylases (2005) (220)
- Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins (2008) (219)
- Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector (1987) (213)
- LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes (1991) (205)
- HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1 (2007) (197)
- Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells (2003) (176)
- Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. (1998) (175)
- Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor (1997) (173)
- A Block to Human Immunodeficiency Virus Type 1 Assembly in Murine Cells (2000) (161)
- Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. (1998) (148)
- Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase (2009) (133)
- Restriction of diverse retroviruses by SAMHD1 (2013) (132)
- The Vpx Lentiviral Accessory Protein Targets SAMHD1 for Degradation in the Nucleus (2012) (132)
- The θ-Defensin, Retrocyclin, Inhibits HIV-1 Entry (2003) (126)
- LD78β, A Non-allelic Variant of Human MIP-1α (LD78α), Has Enhanced Receptor Interactions and Potent HIV Suppressive Activity* (1999) (117)
- Mutational Alteration of Human Immunodeficiency Virus Type 1 Vif Allows for Functional Interaction with Nonhuman Primate APOBEC3G (2006) (116)
- Human Immunodeficiency Virus Type 1 Modified To Package Simian Immunodeficiency Virus Vpx Efficiently Infects Macrophages and Dendritic Cells (2011) (108)
- Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies (2021) (105)
- Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent. (2009) (100)
- Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4 (1993) (98)
- Association of Chemokine-mediated Block to HIV Entry with Coreceptor Internalization* (2002) (95)
- Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor (1995) (94)
- The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef (1994) (91)
- Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants (2021) (87)
- The theta-defensin, retrocyclin, inhibits HIV-1 entry. (2003) (85)
- Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies (2021) (83)
- Mouse-Human Heterokaryons Support Efficient Human Immunodeficiency Virus Type 1 Assembly (2001) (81)
- CCR2-64I Polymorphism Is Not Associated with Altered CCR5 Expression or Coreceptor Function (1999) (77)
- Functional analysis of the proximal CCR5 promoter. (1998) (72)
- Recent insights into HIV-1 Vif. (2004) (69)
- Reversed Functional Organization of Mouse and Human APOBEC3 Cytidine Deaminase Domains* (2006) (66)
- Evidence for an Activation Domain at the Amino Terminus of Simian Immunodeficiency Virus Vpx (2009) (66)
- Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies (2021) (64)
- HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. (2003) (62)
- Cloning of terminal transferase cDNA by antibody screening. (1984) (60)
- Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein (2012) (59)
- The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies (2021) (57)
- B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV (2021) (57)
- An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2 (2020) (55)
- Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes (2021) (53)
- B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies (2021) (53)
- Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin. (2018) (52)
- SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum (2021) (50)
- HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. (2014) (49)
- Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells. (2002) (47)
- Chimeric Human Immunodeficiency Virus Type 1 Containing Murine Leukemia Virus Matrix Assembles in Murine Cells (2002) (45)
- The Cargo-Binding Domain of Transportin 3 Is Required for Lentivirus Nuclear Import (2011) (43)
- Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion. (2004) (43)
- Inhibition of CUL4A Neddylation Causes a Reversible Block to SAMHD1-Mediated Restriction of HIV-1 (2013) (43)
- Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. (2003) (42)
- A DNA Sequence Recognition Loop on APOBEC3A Controls Substrate Specificity (2014) (40)
- Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera (2021) (39)
- Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities (2021) (34)
- Accessories to the crime: Recent advances in HIV accessory protein biology (2009) (33)
- Altered expression of CD4, CD54, CD62L, and CCR5 in primary lymphocytes productively infected with the human immunodeficiency virus. (1999) (32)
- Aminooxypentane Addition to the Chemokine Macrophage Inflammatory Protein-1αP Increases Receptor Affinities and HIV Inhibition* (2000) (31)
- HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor. (1999) (31)
- Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies (2022) (28)
- New insights into the role of Vif in HIV-1 replication. (2004) (26)
- Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy (2022) (26)
- SAMHD1 Has Differential Impact on the Efficacies of HIV Nucleoside Reverse Transcriptase Inhibitors (2014) (25)
- IFN-ε protects primary macrophages against HIV infection. (2016) (24)
- Faculty Opinions recommendation of Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. (2011) (24)
- SAMHD1 Restricts HIV-1 Replication and Regulates Interferon Production in Mouse Myeloid Cells (2014) (24)
- Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies (2022) (22)
- New developments in the biology and treatment of HIV. (1998) (22)
- 2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells. (1988) (21)
- Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice. (2019) (21)
- Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3. (2014) (20)
- SARS-CoV-2 Infects Syncytiotrophoblast and Activates Inflammatory Responses in the Placenta (2021) (20)
- Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry. (2000) (20)
- The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target (2021) (20)
- Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5 (2016) (18)
- Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies (2022) (17)
- A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse* (2016) (16)
- TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes (2016) (16)
- Vpx-containing Dendritic Cell Vaccine Vectors Induce CTLs and Reactivate Latent HIV-1 in vitro (2015) (16)
- High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals (2021) (15)
- The terminal deoxynucleotidyltransferase gene is located on human chromosome 10 (10q23----q24) and on mouse chromosome 19. (1986) (14)
- SARS-CoV-2 Omicron BA.2 Variant Evades Neutralization by Therapeutic Monoclonal Antibodies. (2022) (14)
- DNA damage induces a SAMHD1-mediated block to the infection of macrophages by HIV-1 (2018) (13)
- Degradation of SAMHD1 by Vpx Is Independent of Uncoating (2015) (12)
- Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection (2021) (10)
- Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus. (2015) (10)
- Analysis of Vif-induced APOBEC3G degradation using an alpha-complementation assay. (2007) (9)
- High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization (2020) (9)
- The innate immune response to HIV-1: to sense or not to sense. (2014) (8)
- Erratum: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates (2012) (8)
- B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies (2021) (7)
- a-Complementation assay for HIVenvelope glycoprotein-mediated fusion (2004) (7)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (7)
- HIV recent advances in AIDS research: genetics, molecular biology and immunology. (1999) (6)
- The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition (2020) (6)
- Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest (2014) (6)
- Measurement of terminal deoxynucleotidyl transferase mrna in clinical samples: A new parameter in analysis of leukemia cells (1987) (5)
- Variable susceptibility of intestinal organoid–derived monolayers to SARS-CoV-2 infection (2022) (5)
- Corrigendum: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates (2013) (5)
- The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition (2020) (4)
- Analysis of Vif-induced APOBEC3G Degradation Using an α-Complementation Assay (2007) (4)
- Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection. (2020) (4)
- High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens (2022) (4)
- Directly injected lentiviral vector–based T cell vaccine protects mice against acute and chronic viral infection (2022) (3)
- Production and Use of HIV‐1 Luciferase Reporter Viruses (2003) (3)
- Inhibition of Cul4A neddylation causes a reversible (2013) (3)
- HIV co-receptor identification: good or bad news for drug discovery? (1997) (3)
- Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model (2023) (2)
- A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2 infection in cell culture (2020) (2)
- A cellular cofactor in HIV-1 assembly: INI1 is also an "outtie". (2002) (2)
- Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions (2022) (2)
- Erratum: The cytoplasmic domain of CD4 is sufficient for its down- regulation from the cell surface by human immunodeficiency virus type 1 Nef (Journal of Virology 68:5 (3095)) (1994) (2)
- Review 2: "Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152" (2021) (1)
- Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest (2014) (1)
- Use of Luciferase Reporter Viruses for Studying HIV Entry. (1999) (1)
- Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens (2021) (1)
- Toll-like receptor agonist R848 blocks Zika virus replication in human monocytes by inducing the antiviral protein viperin (2018) (1)
- Faculty Opinions recommendation of Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression. (2019) (1)
- Delta-Omicron recombinant escapes therapeutic antibody neutralization (2022) (1)
- Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection (2023) (1)
- Faculty Opinions recommendation of Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. (2014) (1)
- A Soluble ACE2 Microbody Protein Fused to a Single Immunoglobulin Fc Domain is a Potent Inhibitor of SARS-CoV-2 Infection (2020) (0)
- Evidence for an Activation Domain at the Amino Terminus of Simian Immunodeficiency Virus Vpx (cid:1) † (2009) (0)
- Faculty Opinions recommendation of HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. (2011) (0)
- GUEST COMMENTARY Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins (2009) (0)
- tropism . murine leukemia virus vectors with variable Packaging system for rapid production of (2003) (0)
- Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model (2023) (0)
- Envelope Pseudotypes of HIV and HTLV (1991) (0)
- Chemokine Receptors in HIV Infection and AIDS (2021) (0)
- Philadelphia chromosome-positive human the BCR / ABL tyrosine kinase oncogene of BCR first exon sequences specifically activate (2003) (0)
- Honing the T cell response to HIV: Turning off the noise (2021) (0)
- Faculty Opinions recommendation of Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. (2013) (0)
- Faculty Opinions recommendation of Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. (2012) (0)
- Abstract B121: Checkpoint inhibitor vaccine stimulates antitumor T-cells that block tumor growth (2019) (0)
- Human Immunodeficiency Virus Type 1 Modified To Package Simian Immunodeficiency Virus Vpx Efficiently Infects Macrophages and Dendritic Cells (cid:1) † (2011) (0)
- Delta-Omicron recombinant escapes therapeutic antibody neutralization (2023) (0)
- Faculty Opinions recommendation of The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F. (2010) (0)
- A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2. Tada et al (2020) (0)
- Faculty Opinions recommendation of Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model. (2019) (0)
- Vpu-Induced Degradation ofCD4:Requirement forSpecific AminoAcidResidues intheCytoplasmic DomainofCD4 (1993) (0)
- Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy (2023) (0)
- Engineered multivalent self-assembled binder protein against SARS-CoV-2 RBD (2022) (0)
- Evolution of HIV Cell Tropism and Coreceptor Usage During Infection of Individual Hosts (2003) (0)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (0)
- TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes (2016) (0)
- Restriction of diverse retroviruses by SAMHD1 (2013) (0)
- DNA damage induces a SAMHD1-mediated block to the infection of macrophages by HIV-1 (2018) (0)
- Interferon epsilon protects primary macrophages against HIV infection (2017) (0)
- Faculty Opinions recommendation of Vaccine protection against Zika virus from Brazil. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nathaniel R. Landau?
Nathaniel R. Landau is affiliated with the following schools:
